Results 121 to 130 of about 28,189 (202)

Dimethyl fumarate and mitochondrial physiology: implications for neurological disorders. [PDF]

Front Pharmacol
de Oliveira MR.
europepmc   +1 more source

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models. [PDF]

Oncol Res
Gousseau P, Genest L, Froget G, Rupp T.
europepmc   +1 more source

Cytomegalovirus Infection in a Multiple Sclerosis Patient on Dimethyl Fumarate. [PDF]

Case Rep Neurol Med
Larsen N.
europepmc   +1 more source

Repurposing dimethyl fumarate for cancer therapy: current evidence and future directions. [PDF]

Front Pharmacol
Zhang M, Jing Y, Cui Q.
europepmc   +1 more source

Acute retinal necrosis associated with dimethyl fumarate. [PDF]

Mult Scler
Paisey C, Curtin K, Epps SJ, Rice CM.
europepmc   +1 more source

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. [PDF]

Int J Mol Sci
Mingione A, Corona A, Monzani C, Zollo A, Cirocco C, Zaccone T, Scavone M, Podda GM, Signorelli P, Miozzo M, Priori A, Martinelli-Boneschi F.   +11 more
europepmc   +1 more source

A Randomised, Double-Blind Study Comparing the Gastrointestinal Tolerability of Tegomil Fumarate Versus Dimethyl Fumarate in Healthy Volunteers. [PDF]

Neurol Ther
Fonseca M, Bauzà Valverde G, Bendarraz A, Catalán Flores C, Sharma VM.   +4 more
europepmc   +1 more source

Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort. [PDF]

Dermatol Pract Concept
Giunta A, Esposito M, Campione E, Burlando M, Caldarola G, Lora V, Diotallevi F, Tolino E, Silvi G, Cozzani E, Shumak RG, Fidanza R, Antonetti P, Pinto LM, Mirisola V, Fargnoli MC, Bianchi L, Prignano F.   +17 more
europepmc   +1 more source

Dimethyl Fumarate Treatment for Psoriasis in Real-World Clinical Practice: An Analysis from the Swiss Registry. [PDF]

Dermatology
Maul LV, Ak M, Cerminara SE, Simic D, Gössinger EV, Roider E, Darzina A, Zink A, Oyanguren Monferrer I, Oestereich F, Mateu E, Navarini AA, Kündig T, Maul JT.   +13 more
europepmc   +1 more source

Fracture Risk Associated With Dimethyl Fumarate Treatment in Multiple Sclerosis Patients: Population Heterogeneity and Temporal Patterns. [PDF]

CNS Neurosci Ther
He D, Di J, Jiang P, Liu L, Wang F, Xiang C, Xiang C.   +6 more
europepmc   +1 more source